J W E Jocken1, G H Goossens1, H Popeijus1, Y Essers1, N Hoebers1, E E Blaak1. 1. Department of Human Biology, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, The Netherlands.
Abstract
BACKGROUND/ OBJECTIVES: Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) are key enzymes involved in intracellular lipid catabolism. We have previously shown decreased expression and activity of these lipases in adipose tissue of obese insulin resistant individuals. Here we hypothesized that lipase deficiency might impact on insulin sensitivity and metabolic homeostasis in adipocytes not just by enhancing lipid accumulation, but also by altering lipid and carbohydrate catabolism in a peroxisome proliferator-activated nuclear receptor (PPAR)-dependent manner. METHODS: To address our hypothesis, we performed a series of in vitro experiments in a human white adipocyte model, the human multipotent adipose-derived stem (hMADS) cells, using genetic (siRNA) and pharmacological knockdown of ATGL and/or HSL. RESULTS: We show that ATGL and HSL knockdown in hMADS adipocytes disrupted mitochondrial respiration, which was accompanied by a decreased oxidative phosphorylation (OxPhos) protein content. This lead to a reduced exogenous and endogenous palmitate oxidation following ATGL knockdown, but not in HSL deficient adipocytes. ATGL deficiency was followed by excessive triacylglycerol accumulation, and HSL deficiency further increased diacylglycerol accumulation. Both single and double lipase knockdown reduced insulin-stimulated glucose uptake, which was attributable to impaired insulin signaling. These effects were accompanied by impaired activation of the nuclear receptor PPARα, and restored on PPARα agonist treatment. CONCLUSIONS: The present study indicates that lipase deficiency in human white adipocytes contributes to mitochondrial dysfunction and insulin resistance, in a PPARα-dependent manner. Therefore, modulation of adipose tissue lipases may provide a promising strategy to reverse insulin resistance in obese and type 2 diabetic patients.
BACKGROUND/ OBJECTIVES:Adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) are key enzymes involved in intracellular lipid catabolism. We have previously shown decreased expression and activity of these lipases in adipose tissue of obese insulin resistant individuals. Here we hypothesized that lipase deficiency might impact on insulin sensitivity and metabolic homeostasis in adipocytes not just by enhancing lipid accumulation, but also by altering lipid and carbohydrate catabolism in a peroxisome proliferator-activated nuclear receptor (PPAR)-dependent manner. METHODS: To address our hypothesis, we performed a series of in vitro experiments in a human white adipocyte model, the human multipotent adipose-derived stem (hMADS) cells, using genetic (siRNA) and pharmacological knockdown of ATGL and/or HSL. RESULTS: We show that ATGL and HSL knockdown in hMADS adipocytes disrupted mitochondrial respiration, which was accompanied by a decreased oxidative phosphorylation (OxPhos) protein content. This lead to a reduced exogenous and endogenous palmitate oxidation following ATGL knockdown, but not in HSL deficient adipocytes. ATGL deficiency was followed by excessive triacylglycerol accumulation, and HSL deficiency further increased diacylglycerol accumulation. Both single and double lipase knockdown reduced insulin-stimulated glucose uptake, which was attributable to impaired insulin signaling. These effects were accompanied by impaired activation of the nuclear receptor PPARα, and restored on PPARα agonist treatment. CONCLUSIONS: The present study indicates that lipase deficiency in human white adipocytes contributes to mitochondrial dysfunction and insulin resistance, in a PPARα-dependent manner. Therefore, modulation of adipose tissue lipases may provide a promising strategy to reverse insulin resistance in obese and type 2 diabeticpatients.
Authors: Guenter Haemmerle; Robert Zimmermann; Marianne Hayn; Christian Theussl; Georg Waeg; Elke Wagner; Wolfgang Sattler; Thomas M Magin; Erwin F Wagner; Rudolf Zechner Journal: J Biol Chem Date: 2001-11-20 Impact factor: 5.157
Authors: Johan W E Jocken; Dominique Langin; Egbert Smit; Wim H M Saris; Carine Valle; Gabby B Hul; Cecilia Holm; Peter Arner; Ellen E Blaak Journal: J Clin Endocrinol Metab Date: 2007-03-13 Impact factor: 5.958
Authors: Erin E Kershaw; Jonathan K Hamm; Linda A W Verhagen; Odile Peroni; Masa Katic; Jeffrey S Flier Journal: Diabetes Date: 2006-01 Impact factor: 9.461
Authors: Siobhán E McQuaid; Leanne Hodson; Matthew J Neville; A Louise Dennis; Jane Cheeseman; Sandy M Humphreys; Toralph Ruge; Marjorie Gilbert; Barbara A Fielding; Keith N Frayn; Fredrik Karpe Journal: Diabetes Date: 2010-10-13 Impact factor: 9.461
Authors: Qing Xu; Edwin C M Mariman; Nadia J T Roumans; Roel G Vink; Gijs H Goossens; Ellen E Blaak; Johan W E Jocken Journal: Adipocyte Date: 2018-02-05 Impact factor: 4.534
Authors: Gang Li; Xin Li; Li Yang; Shuyue Wang; Yulin Dai; Baharan Fekry; Lucas Veillon; Lin Tan; Rebecca Berdeaux; Kristin Eckel-Mahan; Philip L Lorenzi; Zhongming Zhao; Richard Lehner; Kai Sun Journal: Life Sci Alliance Date: 2022-04-22
Authors: Johan W E Jocken; Manuel A González Hernández; Nicole T H Hoebers; Christina M van der Beek; Yvonne P G Essers; Ellen E Blaak; Emanuel E Canfora Journal: Front Endocrinol (Lausanne) Date: 2018-01-11 Impact factor: 5.555
Authors: Johan W E Jocken; Dorien Reijnders; Emanuel E Canfora; Mark V Boekschoten; Joghum Plat; Gijs H Goossens; Ellen E Blaak Journal: Adipocyte Date: 2018-04-25 Impact factor: 4.534